BioVie Secures All Scientific Approvals Needed to Receive Additional $12.6 Million of Grant Funding to Launch Planned Phase 2 Trial to Evaluate Bezisterim in Long COVID
Stock Information for BioVie Inc.
Loading
Please wait while we load your information from QuoteMedia.